Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ophthotech Corp (NASDAQ:OPHT)

50.87
Delayed Data
As of Feb 05
 -2.86 / -5.32%
Today’s Change
35.72
Today|||52-Week Range
80.00
-35.22%
Year-to-Date

Today’s Trading

Previous close53.73
Today’s open53.45
Day’s range50.18 - 54.95
Volume421,478
Average volume (3 months)524,467
Market cap$1.8B
Dividend yield--
Data as of 3:59pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+53.47%
Earnings growth (this year)-13.43%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales36.17
Price/Book11.75

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc-1.55-3.15%
KITEKite Pharma Inc-5.72-12.12%
RDUSRadius Health Inc-0.81-2.53%
NVAXNovavax Inc-0.07-1.43%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateFebruary 25, 2016
EPS forecast (this quarter)-$1.28
Annual revenue (last year)$41.3M
Annual profit (last year)-$98.2M
Net profit margin-237.98%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
David R. Guyer
President &
Vice Chairman
Samir Chandrakant Patel
Corporate headquarters
New York, New York

Forecasts

Partner Offers